Cholesterol Drug Cuts Risk of Catching Pneumonia, Study Finds
This article is for subscribers only.
Patients taking AstraZeneca Plc’s cholesterol-lowering medicine Crestor in a study were less likely to develop pneumonia, a finding that potentially will broaden use of such drugs.
The result supports earlier research suggesting drugs in this class, called statins, prevent deaths from pneumonia. The latest study, an analysis of a 17,000-person clinical trial that ended in 2008, was presented today, in Boston, at the Interscience Conference on Antimicrobial Agents & Chemotherapy.